Dose-dependent immunomodulatory effects of 10-hydroxy-2-decenoic acid on human monocyte-derived dendritic cells

Journal of Functional Foods

Volumn 5, Issue 2, 2013, Pages 838-846

  Mihajlovic, Dusan ^a,b   Rajkovic, Ivan ^a   Chinou, Ioanna ^c   Colic, Miodrag ^a,d  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b University of Kragujevac Medical Faculty   (Serbia)

^c UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF NI   (Serbia)

Author keywords

10 Hydroxy 2 decenoic acid; Apoptosis; Cytokines; Monocyte derived dendritic cells; Royal jelly

Indexed keywords

EID: 84876741590     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.01.031     Document Type: Article

References (40)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
2. Bincoletto C., Eberlin S., Figueiredo C.A., Luengo M.B., Queiroz M.L. Effects produced by Royal Jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. International Immunopharmacology 2005, 5:679-688.
3. Bloodworth B.C., Harn C.S., Hock C.T., Boon Y.O. Liquid chromatographic determination of trans-10-hydroxy-2-decenoic acid content of commercial products containing royal jelly. Journal of AOAC International 1995, 78:1019-1023.
4. Colic M., Jandric D., Stojic-Vukanic Z., Antic-Stankovic J., Popovic P., Vasilijic S., et al. Differentiation of human dendritic cells from monocytes in vitro using granulocyte-macrophage colony stimulating factor and low concentration of interleukin-4. Vojnosanitetski Pregled 2003, 60:531-538.
5. De Smedt T., Pajak B., Muraille E., Lespagnard L., Heinen E., De Baetselier P., et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. Journal of Experimental Medicine 1996, 184:1413-1424.
6. Dzopalic T., Dragicevic A., Vasilijic S., Vucevic D., Majstorovic I., Bozic B., et al. Loxoribine, a selective Toll-like receptor 7 agonist, induces maturation of human monocyte-derived dendritic cells and stimulates their Th-1- and Th-17-polarizing capability. International Immunopharmacology 2010, 10:1428-1433.
7. Dzopalic T., Vucevic D., Tomic S., Djokic J., Chinou I., Colic M. 3,10-Dihydroxy-decanoic acid, isolated from royal jelly, stimulates Th1 polarising capability of human monocyte-derived dendritic cells. Food Chemistry 2011, 126:1211-1217.
8. El-Nekeety A.A., El-Kholy W., Abbas N.F., Ebaid A., Amra H.A., Abdel-Wahhab M.A. Efficacy of royal jelly against the oxidative stress of fumonisin in rats. Toxicon 2007, 50:256-269.
9. Fujii S., Liu K., Smith C., Bonito A.J., Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. Journal of Experimental Medicine 2004, 199:1607-1618.
10. Gasic S., Vucevic D., Vasilijic S., Antunovic M., Chinou I., Colic M. Evaluation of the immunomodulatory activities of royal jelly components in vitro. Immunopharmacology and Immunotoxicology 2007, 29:521-536.
11. Glimcher L.H., Murphy K.M. Lineage commitment in the immune system: The T helper lymphocyte grows up. Genes and Development 2000, 14:1693-1711.
12. Grohmann U., Belladonna M.L., Bianchi R., Orabona C., Ayroldi E., Fioretti M.C., et al. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity 1998, 9:315-323.
13. Kannan Y., Yu J., Raices R.M., Seshadri S., Wei M., Caligiuri M.A., et al. IkappaBzeta augments IL-12- and IL-18-mediated IFN-gamma production in human NK cells. Blood 2011, 117:2855-2863.
14. Kohno K., Okamoto I., Sano O., Arai N., Iwaki K., Ikeda M., et al. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Bioscience, Biotechnology, and Biochemistry 2004, 68:138-145.
15. Kojima H., Aizawa Y., Yanai Y., Nagaoka K., Takeuchi M., Ohta T., et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. Journal of Immunology 1999, 162:5063-5069.
16. Lee J., Rhee M.H., Kim E., Cho J.Y. BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediators of Inflammation 2012, 2012:416036.
17. Leon B., Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunology and Cell Biology 2008, 86:320-324.
18. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nature Reviews. Immunology 2002, 2:725-734.
19. Majtan J., Kovacova E., Bilikova K., Simuth J. The immunostimulatory effect of the recombinant apalbumin 1-major honeybee royal jelly protein-on TNFalpha release. International Immunopharmacology 2006, 6:269-278.
20. Matsui T., Yukiyoshi A., Doi S., Sugimoto H., Yamada H., Matsumoto K. Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. Journal of Nutritional Biochemistry 2002, 13:80-86.
21. Melliou E., Chinou I. Chemistry and bioactivity of royal jelly from Greece. Journal of Agricultural and Food Chemistry 2005, 53:8987-8992.
22. Messmer D., Hatsukari I., Hitosugi N., Schmidt-Wolf I.G., Singhal P.C. Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation. Molecular Medicine 2006, 12:284-290.
23. Oka H., Emori Y., Kobayashi N., Hayashi Y., Nomoto K. Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses. International Immunopharmacology 2001, 1:521-532.
24. Okamoto I., Taniguchi Y., Kunikata T., Kohno K., Iwaki K., Ikeda M., et al. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sciences 2003, 73:2029-2045.
25. Park E., Lee S.-M., Lee J.e., Kim J.-H. Anti-inflammatory activity of mulberry leaf extract through inhibition of NF-κB. Journal of Functional Foods 2013, 5:178-186.
26. Patel N.G., Haydak M.H., Gochnauer T.A. Electrophoretic components of the proteins in honeybee larval food. Nature 1960, 186:633-634.
27. Plettner E., Slessor K.N., Winston M.L. Biosynthesis of mandibular acids in honeybees (apis mellifera): de novo synthesis, route of fatty acid hydroxylation and caste selective β-oxidation. Insect Biochemistry and Molecular Biology 1998, 28:31-42.
28. Pollet S., Bottex-Gauthier C., Li M., Potier P., Favier A., Vidal D. Insight into some of the signaling pathways triggered by a lipid immunomodulator. Immunopharmacology and Immunotoxicology 2002, 24:527-546.
29. Ramadan M.F., Al-Ghamdi A. Bioactive compounds and health-promoting properties of royal jelly: A review. Journal of Functional Foods 2012, 4:39-52.
30. Sauerwald N., Polster J., Bengsch E., Niessen L., Vogel R.F. Combined antibacterial and antifungal properties of water soluble fractions of royal jelly. Advances in Food Sciences 1998, 20:46-52.
31. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: An overview of signals, mechanisms and functions. Journal of Leukocyte Biology 2004, 75:163-189.
32. Snijders A., Kalinski P., Hilkens C.M., Kapsenberg M.L. High-level IL-12 production by human dendritic cells requires two signals. International Immunology 1998, 10:1593-1598.
33. Steinman R.M., Hemmi H. Dendritic cells: Translating innate to adaptive immunity. Current Topics in Microbiology and Immunology 2006, 311:17-58.
34. Sugiyama T., Takahashi K., Tokoro S., Gotou T., Neri P., Mori H. Inhibitory effect of 10-hydroxy-trans-2-decenoic acid on LPS-induced IL-6 production via reducing IkappaB-zeta expression. Innate Immunity 2012, 18:429-437.
35. Sver L., Orsolic N., Tadic Z., Njari B., Valpotic I., Basic I. A royal jelly as a new potential immunomodulator in rats and mice. Comparative Immunology, Microbiology and Infectious Diseases 1996, 19:31-38.
36. Takahashi K., Sugiyama T., Tokoro S., Neri P., Mori H. Inhibition of interferon-gamma-induced nitric oxide production by 10-hydroxy-trans-2-decenoic acid through inhibition of interferon regulatory factor-8 induction. Cellular Immunology 2012, 273:73-78.
37. Vittek J. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 1995, 51:927-935.
38. Vo T.-S., Kim S.-K. Fucoidans as a natural bioactive ingredient for functional foods. Journal of Functional Foods 2012, 10.1016/j.jff.2012.08.007.
39. Vucevic D., Melliou E., Vasilijic S., Gasic S., Ivanovski P., Chinou I., et al. Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro. International Immunopharmacology 2007, 7:1211-1220.
40. Yang X.Y., Yang D.S., Wei Z., Wang J.M., Li C.Y., Hui Y., et al. 10-Hydroxy-2-decenoic acid from Royal jelly: A potential medicine for RA. Journal of Ethnopharmacology 2010, 128:314-321.